# Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma

> **NCT00086801** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 104 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** doxorubicin hydrochloride
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** vinblastine
- **PROCEDURE:** fludeoxyglucose F 18 positron-emission tomography (PET) scan
- **PROCEDURE:** CT scan

## Key facts

- **NCT ID:** NCT00086801
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-03
- **Final completion:** 2011-05
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2016-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086801, "Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00086801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*